Roche, the Swiss-based international pharmaceutical company, announced a $50 billion US investment that will create more than 12,000 jobs, and expand manufacturing and research facilities. The investment will take place over the next five years and is expected to create more than 12,000 US jobs.

According to CNBC, “The pharma giant will inject cash into creating new state-of-the-art research and development (R&D) sites, while bolstering and expanding manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California. A new R&D site in Massachusetts will be used for AI research and act as a hub for research into cardiovascular, renal and metabolism treatments.”

Included are plans to build a new 900,000-square foot manufacturing facility “to support Roche’s expanding portfolio of next generation weight loss medicines.”